CClinicalTrials.gg
RecruitingNCT06505421Updated Jul 17, 2024

Eccentric Exercise and Fatigue in Multiple Sclerosis

An observational study in Multiple Sclerosis and Fatigue, sponsored by Hunter College of City University of New York. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-07-17.

Sponsored by Hunter College of City University of New York · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Jul 2024; still recruiting 2 years 3 months later.
Study type
Observational
Model
Case-crossover
Time perspective
Retrospective
Enrollment
30
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The goal of this observational study is to compare the impact of eccentric resistance training to traditional resistance training on fatigue in persons with multiple sclerosis (MS). The primary question this study is asking is the following: is eccentric resistance training more fatiguing than traditional resistance training in persons with MS?. Participants will be asked to come for two sessions for two weeks. In the first week, subjects will undergo a bout of either traditional or eccentric resistance training. The next day they will return to assess their level of fatigue. The following week the subject will return and undergo whatever type of training they did not experience the first week, and it's effects on fatigue will again be assessed. The difference between the subjects level of fatigue for either condition will be compared.

Read the detailed description

Persons with multiple sclerosis (MS) have mobility deficits. Exercise is commonly used to treat these mobility deficits, but must be done so judiciously in order to limit the effects of fatigue, one of the most common disease findings. In persons with MS ,fatigue can limit the amount of exercise performed. Eccentric training, where a muscle is lengthened under resistance has been shown to produce greater gains in strength with less energy expenditure when compared to traditional strength training where a muscle is both lengthened and shortened under resistance. However, eccentric strength training has been shown to result in delayed onset muscle soreness, which may also limit how much exercise a person with MS can perform. The purpose of the study is to compare the impact of eccentric versus traditional strength training programs on fatigue and persons with multiple sclerosis. The hypothesis is that there will be no difference in fatigue measurements between the two conditions. If the hypothesis is correct, it will suggest that eccentric training should be the subject of further study to assess it's feasibility and effectiveness, in treating mobility deficits in person with multiple sclerosis.

A randomized crossover design will be used. Ambulatory participants with a diagnosis of MS will be randomized into either a eccentric or traditional training condition. Each training condition will consist of a single session of training. The following day, the patient will return and their levels of fatigue assessed. The next week, the subjects will return and crossover, undergoing whatever type of training they did not experience in the previous week, and the impact of the training will again be assessed.

02

Conditions studied

  • Multiple Sclerosis
  • Fatigue

Keywords

  • Exercise
  • resistance training
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 30 is below the median of 100 across 1,016 observational studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Hunter College of City University of New York is the lead sponsor of 36 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Ambulatory persons with MS

Inclusion criteria

  • Definitive diagnosis of Multiple Sclerosis.
  • Ability to walk for 6 minutes continuously with or without assistive device
  • Ability read, understand and sign and informed consent

Exclusion criteria

Exclusion Criteria:

  • Evidence of recent exacerbation in the last 2 months prior to starting the study
  • Orthopedic, cardiopulmonary, or non -MS neurologic condition that could interfere with carrying out the study protocol
05

Study design

Observational model
Case-crossover
Time perspective
Retrospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Persons with Multiple sclerosis

    Eccentric resistance training , traditional resistance training

    Behavioral: Resistance training

Interventions

  • BehavioralResistance training

    Eccentric resistance training and tradional resistance training

06

What researchers measure

Primary outcomes

  1. 6-Minute walk test

    Subject walks at best possible pace with or without assistive device for 6 minutes. Total distance walked as well as distance per minute is measured

    Time frame: Pre-intervention and post intervention for each condition (eccentric and traditional strength training). There is a 36-48 hour period between the pre-intervention and post intervention for each condition

Secondary outcomes

  1. Visual analog scale of fatigue

    Immediately before and after each 6 minute walk subjects will make a mark on a 100mm line indicating their level of fatigue

    Time frame: Pre-intervention and post-intervention for each condition (eccentric vs traditional strength training). There is a 36-48 hour period between the pre-intervention and post intervention for each condition

07

Study locations

1 of 1 sites recruiting
  • Hunter College, Physical Therapy Department, City University of New York
    New York, New York 10010, United States
    Recruiting
08

References and documents

Publications

  • Patrocinio de Oliveira CE, Moreira OC, Carrion-Yagual ZM, Medina-Perez C, de Paz JA. Effects of Classic Progressive Resistance Training Versus Eccentric-Enhanced Resistance Training in People With Multiple Sclerosis. Arch Phys Med Rehabil. 2018 May;99(5):819-825. doi: 10.1016/j.apmr.2017.10.021. Epub 2017 Nov 27. PubMed 29191417 ↗
  • Wochatz M, Schraplau A, Engel T, Zecher MM, Sharon H, Alt Y, Mayer F, Kalron A. Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis. PLoS One. 2022 Dec 22;17(12):e0270875. doi: 10.1371/journal.pone.0270875. eCollection 2022. Erratum In: PLoS One. 2023 Oct 17;18(10):e0293225. doi: 10.1371/journal.pone.0293225. PubMed 36548298 ↗
  • Gauche E, Couturier A, Lepers R, Michaut A, Rabita G, Hausswirth C. Neuromuscular fatigue following high versus low-intensity eccentric exercise of biceps brachii muscle. J Electromyogr Kinesiol. 2009 Dec;19(6):e481-6. doi: 10.1016/j.jelekin.2009.01.006. Epub 2009 Feb 12. PubMed 19217311 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06505421
Lead sponsor
Hunter College of City University of New York
Responsible party
Herb Karpatkin (Associate professor, City University of New York, School of Public Health) — Principal investigator
First posted
Jul 17, 2024
Start date
Jul 1, 2024
Primary completion
Dec 30, 2025 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Jul 17, 2024

Study contacts

Herbert Karpatkin, DSc
Contact
hkarpatk@hunter.cuny.edu
212-396-7115

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion